Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
Articolo
Data di Pubblicazione:
1992
Citazione:
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients / A. M. Gianni, M. Bregni, S. Siena, M. Magni, M. Di Nicola, F. Lombardi, C. Tarella, A. Pileri, G. Bonadonna. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 10:12(1992 Dec), pp. 1955-62-1962.
Abstract:
This study assessed the efficacy of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) or recombinant human granulocyte colony-stimulating factor (rhG-CSF) in ameliorating the extent and duration of hematologic toxicity after high-dose etoposide cancer therapy.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Diseases; Recombinant Proteins; Humans; Ambulatory Care; Multiple Myeloma; Granulocyte Colony-Stimulating Factor; Adult; Middle Aged; Etoposide; Lymphoma; Female; Male
Elenco autori:
A. M. Gianni, M. Bregni, S. Siena, M. Magni, M. Di Nicola, F. Lombardi, C. Tarella, A. Pileri, G. Bonadonna
Link alla scheda completa: